Follow-The-Filings

Security · featured owners

KYMR Kymera Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.6%
  • $5M
  • 1 new

Who owns this now

Largest portfolio weights among featured holders · max 0.6% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel new 0.59%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.59% New 0.59% 27,000 $3M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 <0.01% Hold 20,000 $2M history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $78.59M $47.07M $39.21M
Gross profit * — $0.00 $0.00
Gross margin * — 0.0% 0.0%
Net income -$146.96M -$223.86M -$311.35M
Net margin * -187.0% -475.6% -794.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $405.32M $510.27M $871.21M
Total non-current assets * $170.44M $467.77M $871.6M
Total assets $0.576B $0.978B $1.74B
Total current liabilities $85.69M $67.77M $83.21M
Total non-current liabilities * $95.1M $74.65M $79.94M
Total equity $0.395B $0.836B $1.58B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$102.83M -$194.5M -$232.89M
Cash from investing $139.89M -$404.08M -$521.06M
Cash from financing $4.19M $608.85M $990.71M
Net change in cash $41.25M $10.27M $236.76M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders